PL377601A1 - Sposoby przewidywania zachowania samobójczego podczas leczenia - Google Patents

Sposoby przewidywania zachowania samobójczego podczas leczenia

Info

Publication number
PL377601A1
PL377601A1 PL377601A PL37760104A PL377601A1 PL 377601 A1 PL377601 A1 PL 377601A1 PL 377601 A PL377601 A PL 377601A PL 37760104 A PL37760104 A PL 37760104A PL 377601 A1 PL377601 A1 PL 377601A1
Authority
PL
Poland
Prior art keywords
ways
during treatment
behavior during
suicidal behavior
predict
Prior art date
Application number
PL377601A
Other languages
English (en)
Inventor
Sridhar Kudaravalli
Elisabeth Marie Leroy
Mihael Hristos Polymeropoulos
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL377601A1 publication Critical patent/PL377601A1/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G01N33/9413—Dopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
PL377601A 2003-02-21 2004-02-20 Sposoby przewidywania zachowania samobójczego podczas leczenia PL377601A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44901803P 2003-02-21 2003-02-21

Publications (1)

Publication Number Publication Date
PL377601A1 true PL377601A1 (pl) 2006-02-06

Family

ID=32908683

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377601A PL377601A1 (pl) 2003-02-21 2004-02-20 Sposoby przewidywania zachowania samobójczego podczas leczenia

Country Status (9)

Country Link
US (1) US20070065821A1 (pl)
EP (1) EP1597392A1 (pl)
JP (1) JP2006518206A (pl)
CN (1) CN1754000A (pl)
AU (1) AU2004213582A1 (pl)
CA (1) CA2516484A1 (pl)
MX (1) MXPA05008793A (pl)
PL (1) PL377601A1 (pl)
WO (1) WO2004074513A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005118848A1 (en) * 2004-06-04 2005-12-15 Novartis Ag Biomarkers for the prediction of responsiveness to clozapine treatment
US8930178B2 (en) 2007-01-04 2015-01-06 Children's Hospital Medical Center Processing text with domain-specific spreading activation methods
US9012143B2 (en) 2007-04-30 2015-04-21 The Ohio State University Research Foundation Polymorphisms in genes affecting ace-related disorders and uses thereof
WO2008144371A1 (en) * 2007-05-16 2008-11-27 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for diagnosing suicidal tendencies
EP2425356B1 (en) 2009-04-27 2019-03-13 Cincinnati Children's Hospital Medical Center Computer implemented system and method for assessing a neuropsychiatric condition of a human subject
WO2011119227A2 (en) * 2010-03-25 2011-09-29 Columbia Northwest Pharmaceuticals, Llc Compositions for the treatment of central nervous system disorders including depression employing novel drug combination therapy to reduce suicidality in patients
AU2012308305B2 (en) * 2011-09-14 2017-11-23 Banyan Biomarkers, Inc. Processes and kits to detect and monitor for diagnostic biomarkers for post traumatic stress disorder (PTSD) and to differentiate between suicidal and non-suicidal form of the disorder
FR2993889B1 (fr) 2012-07-27 2014-08-22 Michelin & Cie Composition de caoutchouc thermo-expansible pour pneumatique
US9938576B1 (en) 2012-09-21 2018-04-10 Ohio State Innovation Foundation Materials and methods for determining metabolizer status in humans
WO2014201515A1 (en) * 2013-06-18 2014-12-24 Deakin University Medical data processing for risk prediction
CA2918054C (en) * 2013-07-11 2022-12-13 The Johns Hopkins University A dna methylation and genotype specific biomarker of suicide attempt and/or suicide ideation
FR3009305A1 (fr) 2013-07-30 2015-02-06 Michelin & Cie Composition de caoutchouc thermo-expansible et pneumatique comportant une telle composition
FR3009306B1 (fr) 2013-07-30 2015-07-31 Michelin & Cie Pneu dont la zone sommet est pourvue d’une couche interne reduisant les bruits de roulage
CA2891830A1 (en) * 2015-05-15 2016-11-15 Centre For Addiction And Mental Health Genetic markers for suicide risk and related methods

Also Published As

Publication number Publication date
CA2516484A1 (en) 2004-09-02
EP1597392A1 (en) 2005-11-23
MXPA05008793A (es) 2006-02-22
WO2004074513A1 (en) 2004-09-02
US20070065821A1 (en) 2007-03-22
JP2006518206A (ja) 2006-08-10
CN1754000A (zh) 2006-03-29
AU2004213582A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
NO20070297A (no) Brønnbehandling
NO20070251A (no) Brønnbehandling
DE602004015286D1 (de) Wäschebehandlungsmittel
DE50310628D1 (de) Erfahren
DE602004011161D1 (de) Kraftfahrzeugschliessanlage
DE602004012421D1 (de) Mer
DE602004003111D1 (de) Tiefen-basiertes Antialiasing
DE502004008190D1 (de) Schalldämpfer
DE602004018936D1 (de) Härtbare zusammensetzung
DE502004006772D1 (de) Wirkwerkzeug-Barre
DE602004001142D1 (de) Schalldämpfer
ATA662003A (de) Trink-mundstück
ATE446959T1 (de) Chromenonindole
DE502004000599D1 (de) Zwischenspeicher
DE502004012042D1 (de) Lichtleitanordnung
ATE406350T1 (de) Prolinylarylacetamide
DE112004002110D2 (de) Behälter-Deckel-Kombination
DE602004030793D1 (de) Asynchrones flimmerreduktionsverfahren
ATA13282004A (de) Massagegerät
NO20043045L (no) Anordning ved tannborste
DE50306766D1 (de) Schalldämpfende Zusammensetzung
DE50310191D1 (de) Zwischenspeicher
NO20034256D0 (no) Behandlingsmetode
NO20031166D0 (no) Behandlingsmetode
DE10316511B4 (de) Teigportionierer

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)